Sites
Tags
- Abemaciclib
- Aciclovir
- Adenosine deaminase
- Aflibercept
- American Society of Health-System Pharmacists
- Aminolevulinic acid
- Amrubicin
- Amsacrine
- Anthracycline
- Anthraquinone
- Antifolate
- Antimetabolite
- Arsenic trioxide
- Ascó
- Asparaginase
- Asparagine
- Azacitidine
- Bibcode
- Biological half-life
- Bleomycin
- Blood
- Bone marrow suppression
- Bone Marrow Transplantation
- Boron
- Boronic acid
- Cabazitaxel
- Camptotheca
- Camptothecin
- Cancer
- Capecitabine
- Carboplatin
- Carboxylic acid
- Carfilzomib
- Carmustine
- CAS Registry Number
- Celecoxib
- Cell Cycle
- ChEMBL
- Chemical formula
- Chemotherapy
- ChemSpider
- Chlorambucil
- Chlormethine
- Cisplatin
- Cladribine
- Clinical trial
- Cochin International Airport
- Cyclin-dependent kinase
- Cyclophosphamide
- Cytarabine
- Cytochrome P450
- Dactinomycin
- DailyMed
- Daunorubicin
- Decitabine
- Dexamethasone
- Dipeptide
- DNA replication
- Docetaxel
- DOI
- Doxorubicin
- DrugBank
- Drug metabolism
- Drug nomenclature
- EHA
- Enasidenib
- Endothelin receptor antagonist
- Entinostat
- Enzyme inhibitor
- Epigallocatechin gallate
- Epirubicin
- Epothilone
- Etoposide
- European Chemicals Agency
- European Medicines Agency
- Exatecan
- Fludarabine
- Fluorouracil
- Food and Drug Administration
- Gastrointestinal tract
- Gemcitabine
- Generic drug
- GSK
- Halogenation
- HDL
- Heart failure
- Histone deacetylase inhibitor
- Hydrazine
- Hydroxycarbamide
- Hypomethylating agent
- Hypotension
- Idarubicin
- Idelalisib
- Ifosfamide
- Imbros
- Incyte
- Intercalation
- International Chemical Identifier
- International Standard Serial Number
- Intravenous therapy
- Irinotecan
- Isatuximab
- Jmol
- KEGG
- Lenalidomide
- Leucine
- Leukopenia
- Liver
- Lomustine
- Lonidamine
- Lucanthone
- Mantle cell lymphoma
- MedlinePlus
- Mercaptopurine
- Metabolism
- Methotrexate
- Microtubule
- Mitomycins
- Mitotane
- Mitotic inhibitor
- Mitoxantrone
- Molar mass
- Multiple myeloma
- Multiplo
- Neuropathy
- Neutropenia
- Nice
- Niraparib
- Novartis
- Olaparib
- Orlowski
- Oxaliplatin
- Paclitaxel
- Palbociclib
- Panobinostat
- PARP inhibitor
- Patient
- Pemetrexed
- Peripheral neuropathy
- Pharmacodynamics
- Pharmacokinetics
- Phases of clinical research
- Phenylalanine
- Phosphodiesterase inhibitor
- Phosphoinositide 3-kinase inhibitor
- Photodynamic therapy
- Photosensitizer
- Plasma protein binding
- Platinum-based antineoplastic
- PMC
- Podophyllum
- Polymerase chain reaction inhibitors
- Porphyrin
- Prednisone
- Pregnancy category
- Prescription drug
- Procarbazine
- Progression-free survival
- Prophylaxis
- Proteasome
- Proteasome inhibitor
- Protein Data Bank
- Protein kinase inhibitor
- PubChem
- Public domain
- PubMed
- Purine analogue
- Receptor antagonist
- Regulation of therapeutic goods
- Retinoid
- Ribociclib
- Robert Orlowski
- Route of administration
- Rucaparib
- Sex steroid
- Shingles
- Side Effects
- S phase
- Standard for the Uniform Scheduling of Medicines and Poisons
- Streptomyces
- Streptozotocin
- Subcutaneous injection
- Talimogene laherparepvec
- Taxane
- Temozolomide
- Teniposide
- Testolactone
- Thiopurine
- Threonine
- Thrombocytopenia
- Tisagenlecleucel
- Topoisomerase inhibitor
- Topotecan
- Tretinoin
- Tumors of the hematopoietic and lymphoid tissues
- Type I topoisomerase
- Ubiquitin
- Valrubicin
- Venetoclax
- Verteporfin
- Vinblastine
- Vincristine
- Vinorelbine
- Vorinostat
- VRD
- Weakness
- WHO Model List of Essential Medicines
- World Health Organization
- Yeast